IT1262479B - Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. - Google Patents
Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine.Info
- Publication number
- IT1262479B IT1262479B ITFI930143A ITFI930143A IT1262479B IT 1262479 B IT1262479 B IT 1262479B IT FI930143 A ITFI930143 A IT FI930143A IT FI930143 A ITFI930143 A IT FI930143A IT 1262479 B IT1262479 B IT 1262479B
- Authority
- IT
- Italy
- Prior art keywords
- diseases
- relaxin
- vessels
- coagulation
- platelet aggregation
- Prior art date
Links
- 102000003743 Relaxin Human genes 0.000 title abstract 2
- 108090000103 Relaxin Proteins 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 3
- 230000015271 coagulation Effects 0.000 title 1
- 238000005345 coagulation Methods 0.000 title 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 title 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 210000005226 corpus cavernosum Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000003899 penis Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000004218 vascular function Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La relassina è risultata efficace in farmaci destinati alla dilatazione di vasi sanguigni, al controllo di malattie trombotiche, alla correzione di alterazioni della funzione vasale in organi umani, quali i corpi cavernosi del pene, all'incremento della produzione e/o liberazione di nitrossido, alla riduzione delle sintesi e/o della liberazione di fibrinogeno circolante.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI930143A IT1262479B (it) | 1993-07-27 | 1993-07-27 | Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. |
CA002145515A CA2145515A1 (en) | 1993-07-27 | 1994-07-26 | Use of relaxin as therapeutic or preventing agent |
DE69434777T DE69434777T2 (de) | 1993-07-27 | 1994-07-26 | Verwendung von Relaxin zur Herstellung von therapeutischer Mittel |
US08/403,878 US5952296A (en) | 1993-07-27 | 1994-07-26 | Method of using relaxin as therapeutic or preventing agent |
PCT/IT1994/000124 WO1995003822A2 (en) | 1993-07-27 | 1994-07-26 | Use of relaxin as therapeutic or preventing agent |
EP94923052A EP0675732B1 (en) | 1993-07-27 | 1994-07-26 | Use of relaxin in the manufacture of therapeutic agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI930143A IT1262479B (it) | 1993-07-27 | 1993-07-27 | Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITFI930143A0 ITFI930143A0 (it) | 1993-07-27 |
ITFI930143A1 ITFI930143A1 (it) | 1995-01-27 |
IT1262479B true IT1262479B (it) | 1996-06-28 |
Family
ID=11350556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITFI930143A IT1262479B (it) | 1993-07-27 | 1993-07-27 | Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1262479B (it) |
-
1993
- 1993-07-27 IT ITFI930143A patent/IT1262479B/it active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITFI930143A1 (it) | 1995-01-27 |
ITFI930143A0 (it) | 1993-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1988006026A3 (en) | Internal prosthesis for the substitution of a part of the human body particularly in vascular surgery | |
DE69126205D1 (en) | Oxidationsresistente analoga des thrombomodulins | |
Langford et al. | All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality | |
AU3275689A (en) | Process for stabilizing human albumin solutions and the solution obtained | |
SE9702860D0 (sv) | New use | |
AU694973B2 (en) | Ultra sound method | |
IL96415A0 (en) | Oral composition for the treatment of inflammatory bowel diseases | |
OA07291A (fr) | Gilet orthopédique de soutien et de contention dans le traitement des traumatisés et des opérés de l'épaule, de la ceinture scapulaire et du membre supérieur. | |
BR0309595A (pt) | Injeção produzida a partir de ixeris sonchifolia hance para o tratamento de doenças vasculares cardiocerebrais e doenças de fundo, e método para a produção da mesma | |
KR900002802A (ko) | 면역억제제로서의 트랜스글루타미나제의 용도 | |
FI952593A0 (fi) | Hyytymistä estävä aine | |
ES2085326T3 (es) | Activador de plasminogeno salivar del murcielago vampiro vpa-alfa1. | |
IE890580L (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
IT1262479B (it) | Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. | |
ATE382378T1 (de) | Implantatmaterial | |
IS5231A (is) | Vefjaþáttur sem hefur áhrif á blóðæðarmyndun | |
SMITH | Subjective experiences during a 32-year period after resurfacing of hands for severe and acute radiation burns | |
Kakkar | Risk factors for secondary venous thromboembolism: Where, when, why and in whom | |
MacKay | A Clinical Effect of Venostasis after 11 Years of Growth: A Case Report. | |
Kustos et al. | Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. II. Effects of the type and localisation of fracture on the urinary excretion of hydroxyproline and glycosaminoglycans | |
Upendra et al. | Traumatic Arteriovenous Fistula of the Scalp-Case Reports | |
EP0485217A3 (en) | Hydantoin derivatives, and their use in preventing and treating diabetic complications and circulatory organ diseases | |
Kondo | Clinical and experimental studies on the continuous pelvic irrigation method using normal saline containing antibiotics; with special references to the application of this method to the kidney after nephrolithotomy in cases of staghorn calculi (author's transl) | |
UA34378A (uk) | Спосіб лікування перелому надколінника | |
Avrutskiĭ et al. | Clinical picture and course of the neuroleptic malignant syndrome (acute febrile neuroleptic encephalopathy) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19980730 |